TrimRx's Blog
What Happens to Your Appetite After Stopping Zepbound?
One of the most common questions patients ask before stopping Zepbound is what’s going to happen to their appetite when the medication clears. It’s…
GLP-1 Medications for People With Disabilities: Access and Considerations
Weight management for people with physical disabilities is a subject that receives far less clinical attention than it deserves, and the arrival of effective…
Ozempic for Athletes: Performance, Recovery, and Body Composition
Athletes considering semaglutide occupy a distinct position in the GLP-1 conversation. The medication’s appetite suppression that makes weight loss feel effortless for most patients…
Ozempic Medications After Bariatric Surgery: What Patients Report
The intersection of GLP-1 medications and bariatric surgery is one of the more clinically complex areas in obesity medicine, and it’s becoming increasingly common…
Ozempic for Executives and High-Stress Professionals: What to Expect
High-stress professional environments create a specific set of conditions that interact with GLP-1 treatment in ways that generic guidance doesn’t address. Irregular schedules, frequent…
Weight Loss Before Pregnancy: Ozempic Timing and Safety Guide
For women who are planning to become pregnant, losing weight before conception is one of the most evidence-backed steps they can take to improve…
GLP-1 Medications After Menopause: What Ozempic Does To A Postmenopausal Body
Postmenopause represents a distinct metabolic state, not simply an extension of perimenopause or a continuation of premenopausal biology at a lower hormone level. Once…
Tirzepatide for Men: How Results Differ From Women
The clinical trials for tirzepatide included both men and women, and the headline results, average weight loss of around 20 percent of body weight…
Semaglutide for Seniors: Safety, Dosing, and What to Expect
Adults 65 and older are one of the fastest-growing groups seeking GLP-1 medications, and for good reason. Obesity in older adults is associated with…
